Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jacques Izopet
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Living Beings
Physiology
Procedures
Concepts & Ideas
Geographic Areas
Sign-in to see full Profile
Network (preview)
64
Rostaing, Lionel
47
Pasquier, Christophe
37
Kamar, Nassim
32
Alric, Laurent
30
Durand, Dominique
29
Puel, Jacqueline
27
Sandres-Sauné, Karine
26
Vinel, Jean-Pierre
24
Massip, Patrice
22
Duffaut, Michel
19
Sandres-Saune, Karine
18
Sandres, K
18
Legrand-Abravanel, Florence
18
Descamps, Diane
18
Dubois, Martine
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jacques Izopet (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Legrand-Abravanel Florence; Colson Philippe; Leguillou-Guillemette Hélène; Alric Laurent; Ravaux Isabelle; Lunel-Fabiani Françoise; Bouviers-Alias Magali; Trimoulet Pascale; Chaix Marie Laure; Hézode Christophe; Foucher Juliette; Fontaine Hélène; Roque-Afonso Anne-Marie; Gassin Michèle; Schvoerer Evelyne; Gaudy Catherine; Roche Bruno; Doffoël Michel; D'Alteroche Louis; Vallet Sophie; Baazia Yazid; Pozzetto Bruno; Thibault Vincent; Nousbaum Jean-Baptiste; Roulot Dominique; Coppere Henry; Poinard Thierry; Payan Christopher; Izopet Jacques
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
Journal of medical virology 2009;81(12):2029-35.
-
2009: Burgard Marianne; Boufassa Faroudy; Viard Jean-Paul; Garrigue Isabelle; Ruffault Annick; Izopet Jacques; Vabret Astrid; Descamps Diane; Colson Philippe; Seigneurin Jean-Marie; Rouzioux Christine;
Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.
AIDS (London, England) 2009;23(16):2165-71.
-
2009: Pasquier Christophe; Sauné Karine; Raymond Stéphanie; Moinard Nathalie; Daudin Myriam; Bujan Louis; Izopet Jacques
Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.
Journal of clinical microbiology 2009;47(9):2883-7.
-
2009: Raymond Stéphanie; Delobel Pierre; Mavigner Maud; Cazabat Michelle; Souyris Corinne; Encinas Stéphanie; Sandres-Sauné Karine; Pasquier Christophe; Marchou Bruno; Massip Patrice; Izopet Jacques
Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.
Journal of clinical microbiology 2009;47(7):2292-4.
-
2009: Kamar Nassim; Nicot Florence; Izopet Jacques; Rostaing Lionel
Occult hepatitis C virus infection in hemodialysis patients: examining the evidence.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(1):10-2.
-
2009: Martin-Blondel G; Gales A; Bernad J; Cuzin L; Delobel P; Barange K; Izopet J; Pipy B; Alric L
Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection.
Journal of viral hepatitis 2009;16(7):485-91.
-
2009: Mansuy J-M; Mengelle C; Miédougé M; Abravanel F; Izopet J
[Viral hepatitis E]
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2009;16(6):717-20.
-
2009: Laporte Franck; Tap Gérard; Jaafar Acil; Saune-Sandres Karine; Kamar Nassim; Rostaing Lionel; Izopet Jacques
Mathematical modeling of hepatitis C virus transmission in hemodialysis.
American journal of infection control 2009;37(5):403-7.
-
2009: Legrand-Abravanel Florence; Thevenet Isabelle; Mansuy Jean-Michel; Saune Karine; Vischi Françoise; Peron Jean-Marie; Kamar Nassim; Rostaing Lionel; Izopet Jacques
Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections.
Clinical and vaccine immunology : CVI 2009;16(5):772-4.
-
2009: Chaix Marie-Laure; Descamps Diane; Wirden Marc; Bocket Laurence; Delaugerre Constance; Tamalet Catherine; Schneider Veronique; Izopet Jacques; Masquelier Bernard; Rouzioux Christine; Meyer Laurence; Costagliola Dominique;
Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.
AIDS (London, England) 2009;23(6):717-24.
-
2009: Mansuy Jean-Michel; Huynh Anne; Abravanel Florence; Recher Christian; Peron Jean Marie; Izopet Jacques
Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):373-4.
-
2009: Miedouge Marcel; Legrand-Abravanel Florence; Lalanne Colette; Saune Karine; Izopet Jacques
Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;44(2):134-7.
-
2009: Legrand-Abravanel Florence; Mansuy Jean-Michel; Dubois Martine; Kamar Nassim; Peron Jean-Marie; Rostaing Lionel; Izopet Jacques
Hepatitis E virus genotype 3 diversity, France.
Emerging infectious diseases 2009;15(1):110-4.
-
2009: Mavigner Maud; Delobel Pierre; Cazabat Michelle; Dubois Martine; L'faqihi-Olive Fatima-Ezzahra; Raymond Stéphanie; Pasquier Christophe; Marchou Bruno; Massip Patrice; Izopet Jacques
HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
PloS one 2009;4(10):e7658.
-
2009: Legrand-Abravanel Florence; Henquell Cécile; Le Guillou-Guillemette Hélène; Balan Viorica; Mirand Audrey; Dubois Martine; Lunel-Fabiani Francoise; Payan Christopher; Izopet Jacques
Naturally occurring substitutions conferring resistance to hepatitis C virus polymerase inhibitors in treatment-naive patients infected with genotypes 1-5.
Antiviral therapy 2009;14(5):723-30.
-
2008: Izopet Jacques; Kamar Nassim
[Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients]
Médecine sciences : M/S 2008;24(12):1023-5.
-
2008: Kurbanov Fuat; Tanaka Yasuhito; Chub Elena; Maruyama Isao; Azlarova Aziza; Kamitsukasa Hiroshi; Ohno Tomoyoshi; Bonetto Stefania; Moreau Isabelle; Fanning Liam J; Legrand-Abravanel Florence; Izopet Jaques; Naoumov Nikolai; Shimada Takashi; Netesov Sergei; Mizokami Masashi
Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.
The Journal of infectious diseases 2008;198(10):1448-56.
-
2008: Raymond Stéphanie; Delobel Pierre; Mavigner Maud; Cazabat Michelle; Souyris Corinne; Sandres-Sauné Karine; Cuzin Lise; Marchou Bruno; Massip Patrice; Izopet Jacques
Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
AIDS (London, England) 2008;22(14):F11-6.
-
2008: Pasquier Christophe J-M; Moinard Nathalie; Sauné Karine; Souyris Corinne; Lavit Michel; Daudin Myriam; Izopet Jacques; Bujan Louis
Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
AIDS (London, England) 2008;22(14):1894-6.
-
2008: Nicot Florence; Legrand-Abravanel Florence; Lafont Thierry; Dubois Martine; Sauné Karine; Pasquier Christophe; Chatelut Etienne; Izopet Jacques
Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV.
Journal of medical virology 2008;80(9):1523-9.
-
2008: Marcelin Anne-Genevieve; Masquelier Bernard; Descamps Diane; Izopet Jacques; Charpentier Charlotte; Alloui Chakib; Bouvier-Alias Magali; Signori-Schmuck Anne; Montes Brigitte; Chaix Marie-Laure; Amiel Corinne; Santos Georges Dos; Ruffault Annick; Barin Francis; Peytavin Gilles; Lavignon Marc; Flandre Philippe; Calvez Vincent
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2008;52(9):3237-43.
-
2008: Descamps Diane; Assoumou Lambert; Masquelier Bernard; Marcelin Anne-Geneviève; Saidi Souhila; Tamalet Catherine; Cottalorda Jacqueline; Plantier Jean-Christophe; Montes Brigitte; Izopet Jacques; Peytavin Gilles; Yerly Sabine; Schneider Véronique; Delaugerre Constance; Ferré Virginie; Ruffault Annick; Pallier Coralie; Morand-Joubert Laurence; Chaix Marie-Laure; Calvez Vincent; Brun-Vézinet Françoise; Costagliola Dominique;
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.
The Journal of antimicrobial chemotherapy 2008;62(3):451-5.
-
2008: Kamar Nassim; Milioto Olivier; Alric Laurent; El Kahwaji Labib; Cointault Olivier; Lavayssière Laurence; Sauné Karine; Izopet Jacques; Rostaing Lionel
Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients.
Transplantation 2008;86(4):611-4.
-
2008: Kamar Nassim; Mengelle Catherine; Esposito Laure; Guitard Joëlle; Mehrenberger Marion; Lavayssière Laurence; Ribes David; Cointault Olivier; Durand Dominique; Izopet Jacques; Rostaing Lionel
Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
Journal of medical virology 2008;80(6):1012-7.
-
2008: Canivet Cindy; Böhler Torsten; Galvani Sylvain; Péron Jean-Marie; Muscari Fabrice; Alric Laurent; Barange Karl; Salvayre Robert; Negre-Salvayre Anne; Durand Dominique; Suc Bertrand; Izopet Jacques; Thomsen Mogens; Rostaing Lionel; Kamar Nassim
In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation.
Transplant immunology 2008;19(2):112-9.
-
2008: Kamar Nassim; Izopet Jacques; Rostaing Lionel
[Prevalence and incidence of hepatitis C virus in hemodialysis: diagnosis and prevention]
Néphrologie & thérapeutique 2008;4(2):89-91.
-
2008: Wéclawiack Hugo; Kamar Nassim; Mehrenberger Marion; Guilbeau-Frugier Céline; Modesto Anne; Izopet Jacques; Ribes David; Sallusto Federico; Rostaing Lionel
Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(3):1043-7.
-
2008: Kamar Nassim; Selves Janick; Mansuy Jean-Michel; Ouezzani Leila; Péron Jean-Marie; Guitard Joëlle; Cointault Olivier; Esposito Laure; Abravanel Florence; Danjoux Marie; Durand Dominique; Vinel Jean-Pierre; Izopet Jacques; Rostaing Lionel
Hepatitis E virus and chronic hepatitis in organ-transplant recipients.
The New England journal of medicine 2008;358(8):811-7.
-
2008: Mansuy Jean Michel; Legrand-Abravanel Florence; Calot Jean Pierre; Peron Jean Marie; Alric Laurent; Agudo Sylvie; Rech Henri; Destruel François; Izopet Jacques
High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.
Journal of medical virology 2008;80(2):289-93.
-
2008: Izopet Jacques; Marchou Bruno; Charreau Isabelle; Sauné Karine; Tangre Philippe; Molina Jean-Michel; Aboulker Jean-Pierre;
HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
Antiviral therapy 2008;13(4):537-45.
-
2007: Sandres-Sauné K; Abravanel F; Nicot F; Peron J M; Alric L; Boineau J; Pasquier C; Izopet J
Detection and quantitation of HCV RNA using real-time PCR after automated sample processing.
Journal of medical virology 2007;79(12):1821-6.
-
2007: Hmaied Fatma; Legrand-Abravanel Florence; Nicot Florence; Garrigues Natalie; Chapuy-Regaud Sabine; Dubois Martine; Njouom Richard; Izopet Jacques; Pasquier Christophe
Full-length genome sequences of hepatitis C virus subtype 4f.
The Journal of general virology 2007;88(Pt 11):2985-90.
-
2007: Laperche Syria; Bouchardeau Françoise; Thibault Vincent; Pozzetto Bruno; Vallet Sophie; Rosenberg Arielle R; Roque-Afonso Anne-Marie; Gassin Michèle; Stoll-Keller Françoise; Trimoulet Pascale; Gault Elyanne; Chanzy Bruno; Mercier Bernard; Branger Michel; Pawlotsky Jean-Michel; Henquell Cécile; Lunel Françoise; Gaudy-Graffin Catherine; Alain Sophie; Chaix Marie-Laure; Duverlie Gilles; Izopet Jacques; Lefrère Jean-Jacques
Multicenter trials need to use the same assay for hepatitis C virus viral load determination.
Journal of clinical microbiology 2007;45(11):3788-90.
-
2007: Costagliola Dominique; Descamps Diane; Assoumou Lambert; Morand-Joubert Laurence; Marcelin Anne-Geneviève; Brodard Véronique; Delaugerre Constance; Mackiewicz Vincent; Ruffault Annick; Izopet Jacques; Plantier Jean-Christophe; Tamalet Catherine; Yerly Sabine; Saidi Souhaha; Brun-Vezinet Françoise; Masquelier Bernard;
Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):12-8.
-
2007: Mariné-Barjoan Eugènia; Berrébi Alain; Giordanengo Valérie; Favre Sébastien Fournier; Haas Hervé; Moreigne Michel; Izopet Jacques; Tricoire Joelle; Tran Albert; Pradier Christian; Bongain André
HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?
AIDS (London, England) 2007;21(13):1811-5.
-
2007: Hmaïed Fatma; Ben Mamou Myriam; Dubois Martine; Pasquier Christophe; Sandres-Saune Karine; Rostaing Lionel; Slim Amine; Arrouji Zakia; Ben Redjeb Saïda; Izopet Jacques
Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV.
Journal of medical virology 2007;79(8):1089-94.
-
2007: Legrand-Abravanel Florence; Izopet Jacques
[A new system for the culture of hepatitis C virus]
Médecine sciences : M/S 2007;23(6-7):588-9.
-
2007: Péron J M; Bureau C; Poirson H; Mansuy J M; Alric L; Selves J; Dupuis E; Izopet J; Vinel J P
Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.
Journal of viral hepatitis 2007;14(5):298-303.
-
2007: Delobel Pierre; Nugeyre Marie-Thérèse; Cazabat Michelle; Pasquier Christophe; Marchou Bruno; Massip Patrice; Barre-Sinoussi Françoise; Israël Nicole; Izopet Jacques
Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.
Journal of clinical microbiology 2007;45(5):1572-80.
-
2007: Peron Jean-Marie; Danjoux Marie; Kamar Nassim; Missoury Réda; Poirson Hélène; Vinel Jean-Pierre; Mansuy Jean-Michel; Bureau Christophe; Izopet Jacques; Brousset Pierre; Selves Janick
Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France.
Virchows Archiv : an international journal of pathology 2007;450(4):405-10.
-
2007: Legrand-Abravanel Florence; Claudinon Julie; Nicot Florence; Dubois Martine; Chapuy-Regaud Sabine; Sandres-Saune Karine; Pasquier Christophe; Izopet Jacques
New natural intergenotypic (2/5) recombinant of hepatitis C virus.
Journal of virology 2007;81(8):4357-62.
-
2007: Marchou Bruno; Tangre Philippe; Charreau Isabelle; Izopet Jacques; Girard Pierre-Marie; May Thierry; Ragnaud Jean-Marie; Aboulker Jean-Pierre; Molina Jean-Michel;
Intermittent antiretroviral therapy in patients with controlled HIV infection.
AIDS (London, England) 2007;21(4):457-66.
-
2007: Thomas Fabienne; Nicot Florence; Sandres-Sauné Karine; Dubois Martine; Legrand-Abravanel Florence; Alric Laurent; Peron Jean-Marie; Pasquier Christophe; Izopet Jacques
Genetic diversity of HCV genotype 2 strains in south western France.
Journal of medical virology 2007;79(1):26-34.
-
2006: Mengelle Catherine; Abravanel-Legrand Florence; Kamar Nassim; Alain Sophie; Basse Grégoire; Pillet Adèle; Lavayssière Laurence; Suc Bertrand; Izopet Jacques; Rostaing Lionel
Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2006;4(2):537-43.
-
2006: Boulestin Anne; Kamar Nassim; Sandres-Sauné Karine; Alric Laurent; Vinel Jean-Pierre; Rostaing Lionel; Izopet Jacques
Pegylation of IFN-alpha and antiviral activity.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(12):849-53.
-
2006: Péron Jean-Marie; Mansuy Jean-Michel; Izopet Jacques; Vinel Jean-Pierre
[Hepatitis E virus: an emerging disease]
Santé (Montrouge, France) 2006;16(4):239-43.
-
2006: Kamar Nassim; Ribes David; Izopet Jacques; Rostaing Lionel
Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Transplantation 2006;82(7):853-6.
-
2006: Delobel Pierre; Nugeyre Marie-Thérèse; Cazabat Michelle; Sandres-Sauné Karine; Pasquier Christophe; Cuzin Lise; Marchou Bruno; Massip Patrice; Cheynier Rémi; Barré-Sinoussi Françoise; Izopet Jacques; Israël Nicole
Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Journal of virology 2006;80(20):10229-36.
-
2006: Pasquier Christophe; Souyris Corinne; Moinard Nathalie; Bujan Louis; Izopet Jacques
Validation of an automated real-time PCR protocol for detection and quantitation of HIV and HCV genomes in semen.
Journal of virological methods 2006;137(1):156-9.
-
2006: Péron Jean-Marie; Mansuy Jean-Michel; Récher Christian; Bureau Christophe; Poirson Hélène; Alric Laurent; Izopet Jacques; Vinel Jean-Pierre
Prolonged hepatitis E in an immunocompromised patient.
Journal of gastroenterology and hepatology 2006;21(7):1223-4.
-
2006: Kamar N; Selves J; Sandres-Saune K; Durand D; Izopet J; Rostaing L
Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?
Transplantation proceedings 2006;38(5):1329-32.
-
2006: Péron Jean-Marie; Mansuy Jean-Michel; Poirson Hélène; Bureau Christophe; Dupuis Emmanuel; Alric Laurent; Izopet Jacques; Vinel Jean-Pierre
Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A.
Gastroentérologie clinique et biologique 2006;30(5):757-62.
-
2006: Ferradini Laurent; Jeannin Arnaud; Pinoges Loretxu; Izopet Jacques; Odhiambo Didakus; Mankhambo Limangeni; Karungi Gloria; Szumilin Elisabeth; Balandine Serge; Fedida Gaëlle; Carrieri M Patrizia; Spire Bruno; Ford Nathan; Tassie Jean-Michel; Guerin Philippe J; Brasher Chris
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.
Lancet 2006;367(9519):1335-42.
-
2006: Boulestin Anne; Kamar Nassim; Sandres-Sauné Karine; Legrand-Abravanel Florence; Alric Laurent; Vinel Jean-Pierre; Rostaing Lionel; Izopet Jacques
Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
Journal of medical virology 2006;78(3):365-71.
-
2006: Puissant Bénédicte; Roubinet Francis; Massip Patrice; Sandres-Saune Karine; Apoil Pol-André; Abbal Michel; Pasquier Christophe; Izopet Jacques; Blancher Antoine
Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
AIDS research and human retroviruses 2006;22(2):153-62.
-
2006: Laperche Syria; Saune Karine; Dény Paul; Duverlie Gilles; Alain Sophie; Chaix Marie-Laure; Gaudy Catherine; Lunel Françoise; Pawlotsky Jean-Michel; Payan Christopher; Pozzetto Bruno; Tamalet Catherine; Thibault Vincent; Vallet Sophie; Bouchardeau Françoise; Izopet Jacques; Lefrère Jean-Jacques
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.
Journal of clinical microbiology 2006;44(2):614-6.
-
2006: Alric L; Thebault S; Peron J-M; Balard P; Metivier S; Pipy B; Izopet J; Vinel J-P
Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1.
Journal of viral hepatitis 2006;13(2):139-44.
-
2006: Descamps Diane; Delaugerre Constance; Masquelier Bernard; Ruffault Annick; Marcelin Anne-Geneviève; Izopet Jacques; Chaix Marie-Laure; Calvez Vincent; Brun-Vézinet Françoise; Costagliola Dominique
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
Journal of medical virology 2006;78(2):153-60.
-
2006: Hmaied Fatma; Ben Mamou Myriam; Saune-Sandres Karine; Rostaing Lionel; Slim Amine; Arrouji Zakia; Ben Redjeb Saïda; Izopet Jacques
Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission.
Journal of medical virology 2006;78(2):185-91.
-
2005: Kamar Nassim; Rostaing Lionel; Selves Janick; Sandres-Saune Karine; Alric Laurent; Durand Dominique; Izopet Jacques
[The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation]
Néphrologie & thérapeutique 2005;1(6):345-54.
-
2005: Delobel Pierre; Sandres-Sauné Karine; Cazabat Michelle; L'Faqihi Fatima-Ezzahra; Aquilina Christian; Obadia Martine; Pasquier Christophe; Marchou Bruno; Massip Patrice; Izopet Jacques
Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART.
AIDS (London, England) 2005;19(16):1739-50.
-
2005: Pasquier Christophe; Njouom Richard; Ayouba Ahidjo; Dubois Martine; Sartre Michèle Tagni; Vessière Aurelia; Timba Isabelle; Thonnon Jocelyn; Izopet Jacques; Nerrienet Eric
Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon.
Journal of medical virology 2005;77(3):390-8.
-
2005: Savey Anne; Simon Fernando; Izopet Jacques; Lepoutre Agnès; Fabry Jacques; Desenclos Jean-Claude
A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(9):752-60.
-
2005: Legrand-Abravanel F; Nicot F; Boulestin A; Sandres-Sauné K; Vinel J P; Alric L; Izopet Jacques
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection.
Journal of medical virology 2005;77(1):66-9.
-
2005: Izopet Jacques; Sandres-Sauné Karine; Kamar Nassim; Salama Gilles; Dubois Martine; Pasquier Christophe; Rostaing Lionel
Incidence of HCV infection in French hemodialysis units: a prospective study.
Journal of medical virology 2005;77(1):70-6.
-
2005: Njouom Richard; Pasquier Christophe; Ayouba Ahidjo; Tejiokem Mathurin Cyrille; Vessiere Aurelia; Mfoupouendoun Jermie; Tene Gilbert; Eteki Nicole; Lobe Marcel Monny; Izopet Jacques; Nerrienet Eric
Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study.
The American journal of tropical medicine and hygiene 2005;73(2):460-6.
-
2005: Masquelier Bernard; Costagliola Dominique; Schmuck Anne; Cottalorda Jacqueline; Schneider Véronique; Izopet Jacques; Calvez Vincent; Descamps Diane; Poggi Cécile; Brun-Vézinet Françoise;
Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.
Journal of medical virology 2005;76(4):441-6.
-
2005: Kamar Nassim; Rostaing Lionel; Sandres-Saune Karine; Selves Janick; Barthe Carole; Dubois Martine; Alric Laurent; Durand Dominique; Izopet Jacques
Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
Journal of medical virology 2005;76(4):482-8.
-
2005: Kamar Nassim; Rostaing Lionel; Selves Janick; Sandres-Saune Karine; Alric Laurent; Durand Dominique; Izopet Jacques
Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(7):1704-12.
-
2005: Pasquier C; Daudin M; Berrebi A; Izopet J; Bujan L
[HIV risk and procreation, how to reduce HIV and HCV transmission risk for serodiscordant couples?]
Médecine et maladies infectieuses 2005;35 Suppl 2():S26-7.
-
2005: Kamar Nassim; Izopet Jacques; Alric Laurent; Rostaing Lionel
Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients.
Transplantation 2005;79(12):1770-1; author reply 1771.
-
2005: Marcelin Anne-Geneviève; Cohen-Codar Isabelle; King Martin S; Colson Philippe; Guillevic Emmanuel; Descamps Diane; Lamotte Claire; Schneider Véronique; Ritter Jacques; Segondy Michel; Peigue-Lafeuille Hélène; Morand-Joubert Laurence; Schmuck Anne; Ruffault Annick; Palmer Pierre; Chaix Marie-Laure; Mackiewicz Vincent; Brodard Véronique; Izopet Jacques; Cottalorda Jacqueline; Kohli Evelyne; Chauvin Jean-Pierre; Kempf Dale J; Peytavin Gilles; Calvez Vincent
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2005;49(5):1720-6.
-
2005: Kamar Nassim; Mengelle Catherine; Yahyaoui Salah; Sandres-Sauné Karine; Durand Dominique; Izopet Jacques; Rostaing Lionel
Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(1):35-42.
-
2005: Kamar Nassim; Boulestin Anne; Selves Janick; Esposito Laure; Sandres-Saune Karine; Stébenet Michèle; Chatelut Etienne; Durand Dominique; Rostaing Lionel; Izopet Jacques
Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
Journal of medical virology 2005;76(1):61-8.
-
2005: Descamps Diane; Chaix Marie-Laure; André Patrice; Brodard Véronique; Cottalorda Jacqueline; Deveau Christiane; Harzic Martine; Ingrand Didier; Izopet Jacques; Kohli Evelyne; Masquelier Bernard; Mouajjah Said; Palmer Pierre; Pellegrin Isabelle; Plantier Jean-Christophe; Poggi Cécile; Rogez Sylvie; Ruffault Annick; Schneider Véronique; Signori-Schmück Anne; Tamalet Catherine; Wirden Marc; Rouzioux Christine; Brun-Vezinet Françoise; Meyer Laurence; Costagliola Dominique
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
Journal of acquired immune deficiency syndromes (1999) 2005;38(5):545-52.
-
2005: Delobel Pierre; Sandres-Sauné Karine; Cazabat Michelle; Pasquier Christophe; Marchou Bruno; Massip Patrice; Izopet Jacques
R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2005;38(4):382-92.
-
2005: Puissant Bénédicte; Roubinet Francis; Dellacasagrande Jérôme; Massip Patrice; Abbal Michel; Pasquier Christophe; Izopet Jacques; Blancher Antoine
Decrease of Lewis frequency in HIV-infected patients: possible competition of fucosylated antigens with HIV for binding to DC-SIGN.
AIDS (London, England) 2005;19(6):627-30.
-
2005: Laperche Syria; Lunel Françoise; Izopet Jacques; Alain Sophie; Dény Paul; Duverlie Gilles; Gaudy Catherine; Pawlotsky Jean-Michel; Plantier Jean-Christophe; Pozzetto Bruno; Thibault Vincent; Tosetti François; Lefrère Jean-Jacques
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.
Journal of clinical microbiology 2005;43(2):733-9.
-
2005: Kamar Nassim; Borde Jean-Sébastien; Sandres-Saune Karine; Suc Bertrand; Barange Karl; Cointault Olivier; Lavayssière Laurence; Durand Dominique; Izopet Jacques; Rostaing Lionel
Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
Clinical transplantation 2005;19(1):83-9.
-
2005: Bertuzis Rasa; Hardie Alison; Hottentraeger Barbara; Izopet Jacques; Jilg Wolfgang; Kaesdorf Barbara; Leckie Gregor; Leete Jean; Perrin Luc; Qiu Chunfu; Ran Iris; Schneider George; Simmonds Peter; Robinson John
Clinical performance of the LCx HCV RNA quantitative assay.
Journal of virological methods 2005;123(2):171-8.
-
2005: Péron Jean-Marie; Mansuy Jean-Michel; Poirson Hélène; Bureau Christophe; Izopet Jacques; Vinel Jean-Pierre
[Acute hepatitis during pregnancy: hepatitis E virus must be considered]
Gastroentérologie clinique et biologique 2005;29(1):87.
-
2005: Kamar Nassim; Mansuy Jean Michel; Esposito Laure; Legrand-Abravanel Florence; Peron Jean Marie; Durand Dominique; Rostaing Lionel; Izopet Jacques
Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):193-6.
-
2005: Nicot Florence; Legrand-Abravanel Florence; Sandres-Saune Karine; Boulestin Anne; Dubois Martine; Alric Laurent; Vinel Jean-Pierre; Pasquier Christophe; Izopet Jacques
Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France.
The Journal of general virology 2005;86(Pt 1):107-14.
-
2005: Boulestin Anne; Sandres-Saune Karine; Alric Laurent; Pipy Bernard; Dubois Martine; Vinel Jean-Pierre; Izopet Jacques
Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
Antiviral therapy 2005;10(4):499-504.
-
2004: Kamar Nassim; Sandres-Saune Karine; Ribes David; Duffaut Michel; Selves Jannick; Durand Dominique; Izopet Jacques; Rostaing Lionel
Effects of long-term lamivudine therapy in renal-transplant patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(4):298-303.
-
2004: Kamar N; Ribes D; Sandres-Saune K; Suc B; Barange K; Cointault O; Lavayssiere L; Durand D; Izopet J; Rostaing L
Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C.
Transplantation proceedings 2004;36(9):2757-61.
-
2004: Castelain Sandrine; Descamps Véronique; Thibault Vincent; François Catherine; Bonte Dorine; Morel Virginie; Izopet Jacques; Capron Dominique; Zawadzki Patricia; Duverlie Gilles
TaqMan amplification system with an internal positive control for HCV RNA quantitation.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(3):227-34.
-
2004: Mengelle C; Sandres-Sauné K; Miédougé M; Mansuy J M; Bouquies C; Izopet J
Use of two real-time polymerase chain reactions (PCRs) to detect herpes simplex type 1 and 2-DNA after automated extraction of nucleic acid.
Journal of medical virology 2004;74(3):459-62.
-
2004: Mansuy Jean Michel; Peron Jean Marie; Abravanel Florence; Poirson Hélène; Dubois Martine; Miedouge Marcel; Vischi Françoise; Alric Laurent; Vinel Jean Pierre; Izopet Jacques
Hepatitis E in the south west of France in individuals who have never visited an endemic area.
Journal of medical virology 2004;74(3):419-24.
-
2004: Boulestin Anne; Kamar Nassim; Legrand-Abravanel Florence; Sandres-Saune Karine; Alric Laurent; Vinel Jean-Pierre; Rostaing Lionel; Izopet Jacques
Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.
Antimicrobial agents and chemotherapy 2004;48(9):3610-2.
-
2004: Jaafar Acil; Massip Patrice; Sandres-Sauné Karine; Souyris Corinne; Pasquier Christophe; Aquilina Christian; Izopet Jacques
HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.
Journal of medical virology 2004;74(1):8-15.
-
2004: Pasquier C; Sandres-Sauné K; Mansuy J-M; Puissant B; Viraben R; Spenato N; Miédougé M; Massip P; Blancher A; Izopet J
Virological exploration of individuals with discordant HIV screening tests.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;30(3):218-23.
-
2004: Masquelier Bernard; Tamalet Catherine; Montès Brigitte; Descamps Diane; Peytavin Gilles; Bocket Laurence; Wirden Marc; Izopet Jacques; Schneider Véronique; Ferré Virginie; Ruffault Annick; Palmer Pierre; Trylesinski Aldo; Miller Michael; Brun-Vézinet Françoise; Costagliola Dominique;
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients.
Antiviral therapy 2004;9(3):315-23.
-
2004: Lefrère Jean-Jacques; Roudot-Thoraval Françoise; Lunel Françoise; Alain Sophie; Chaix Marie-Laure; Dussaix Elisabeth; Gassin Michèle; Izopet Jacques; Pawlotsky Jean-Michel; Payan Christopher; Stoll-Keller Françoise; Thibault Vincent; Trabaud Mary-Anne; Bettinger Dominique; Bogard Marc; Branger Michel; Buffet-Janvresse Claudine; Charrois Anne; Defer Christine; Laffont Catherine; Lerable Joëlle; Levayer Thierry; Martinot-Peignoux Michèle; Mercier Bernard; Rosenberg Arielle R
Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2004;42(5):2027-30.
-
2004: Kamar Nassim; Rostaing Lionel; Sandres-Saune Karine; Ribes David; Durand Dominique; Izopet Jacques
Amantadine therapy in renal transplant patients with hepatitis C virus infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;30(1):110-4.
-
2004: Legrand-Abravanel F; Sandres-Sauné K; Barange K; Alric L; Moreau J; Desmorat P; Vinel J P; Izopet J
Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin.
The Journal of infectious diseases 2004;189(8):1397-400.
-
2004: Bujan Louis; Daudin Myriam; Matsuda Tomohiro; Righi Laurence; Thauvin Laurence; Berges Laetitia; Izopet Jacques; Berrebi Alain; Massip Patrice; Pasquier Christophe
Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes.
AIDS (London, England) 2004;18(5):757-66.
-
2004: Flandre Philippe; Descamps Diane; Joly Veronique; Meiffredy Vincent; Tamalet Catherine; Izopet Jacques; Brun-Vezinet Francoise
A survival method to estimate the time to occurrence of mutations: an application to thymidine analogue mutations in HIV-1-infected patients.
The Journal of infectious diseases 2004;189(5):862-70.
-
2004: Mansuy Jean Michel; Peron Jean Marie; Bureau Christophe; Alric Laurent; Vinel Jean Pierre; Izopet Jacques
Immunologically silent autochthonous acute hepatitis E virus infection in France.
Journal of clinical microbiology 2004;42(2):912-3.
-
2004: Kamar Nassim; Chatelut Etienne; Manolis Efthymios; Lafont Thierry; Izopet Jacques; Rostaing Lionel
Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(1):140-6.
-
2004: Kamar N; Izopet J; Ribes D; Rostaing L
[Hepatitis C virus infection in renal-transplant patients]
Néphrologie 2004;25(1):9-15.
-
2003: Chaix Marie-Laure; Descamps Diane; Harzic Martine; Schneider Véronique; Deveau Christiane; Tamalet Catherine; Pellegrin Isabelle; Izopet Jacques; Ruffault Annick; Masquelier Bernard; Meyer Laurence; Rouzioux Christine; Brun-Vezinet Françoise; Costagliola Dominique
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.
AIDS (London, England) 2003;17(18):2635-43.
-
2003: Boulestin Anne; Sandres-Saune Karine; Payen Jean-Louis; Rostaing Lionel; Pasquier Christophe; Izopet Jacques
Genetic heterogeneity of the NS5A gene of hepatitis C virus and early response to interferon-alpha.
The Journal of infectious diseases 2003;188(9):1367-70.
-
2003: Njouom Richard; Pasquier Christophe; Ayouba Ahidjo; Gessain Antoine; Froment Alain; Mfoupouendoun Jermie; Pouillot Regis; Dubois Martine; Sandres-Sauné Karine; Thonnon Jocelyn; Izopet Jacques; Nerrienet Eric
High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon.
Journal of medical virology 2003;71(2):219-25.
-
2003: Mengelle C; Sandres-Sauné K; Pasquier C; Rostaing L; Mansuy J-M; Marty M; Da Silva I; Attal M; Massip P; Izopet J
Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay.
Journal of clinical microbiology 2003;41(8):3840-5.
-
2003: Kamar Nassim; Toupance Olivier; Buchler Matthias; Sandres-Saune Karine; Izopet Jacques; Durand Dominique; Rostaing Lionel
Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.
Journal of the American Society of Nephrology : JASN 2003;14(8):2092-8.
-
2003: Kamar Nassim; Sandres-Saune Karine; Selves Janick; Ribes David; Cointault Olivier; Durand Dominique; Izopet Jacques; Rostaing Lionel
Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(1):184-92.
-
2003: Njouom Richard; Pasquier Christophe; Sandres-Sauné Karine; Harter Agnès; Souyris Corinne; Izopet Jacques
Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences.
Journal of virological methods 2003;110(1):1-8.
-
2003: Miédougé M; Rostaing L; Mansuy J M; Sandres-Sauné K; Boudet F; Izopet J
Screening for hepatitis B virus DNA in serum of organ donors and renal transplant recipients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(4):246-8.
-
2003: Kamar Nassim; Rostaing Lionel; Boulestin Anne; Sandres Karine; Dubois Martine; Ribes David; Modesto Anne; Durand Dominique; Izopet Jacques
Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.
Journal of medical virology 2003;69(4):482-8.
-
2003: Njouom Richard; Pasquier Christophe; Ayouba Ahidjo; Sandres-Sauné Karine; Mfoupouendoun Jermie; Mony Lobe Marcel; Tene Gilbert; Thonnon Jocelyn; Izopet Jacques; Nerrienet Eric
Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes.
Journal of medical virology 2003;69(3):384-90.
-
2003: Pasquier Christophe; Bujan Louis; Daudin Myriam; Righi Laurence; Berges Laetitia; Thauvin Laurence; Berrebi Alain; Massip Patrice; Puel Jacqueline; Izopet Jacques
Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV.
Journal of medical virology 2003;69(3):344-9.
-
2003: Flandre Philippe; Descamps Diane; Joly Veronique; Meiffrédy Vincent; Tamalet Catherine; Izopet Jacques; Aboulker Jean-Pierre; Brun-Vézinet Françoise
Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received.
Antiviral therapy 2003;8(1):65-72.
-
2003: Mengelle Catherine; Pasquier Christophe; Rostaing Lionel; Sandres-Sauné Karine; Puel Jacqueline; Berges Laetitia; Righi Laurence; Bouquies Christiane; Izopet Jacques
Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
Journal of medical virology 2003;69(2):225-31.
-
2003: Bourlet Thomas; Levy Rachel; Laporte Silvy; Blachier Stéphane; Bocket Laurence; Cassuto Guy; Chollet Lionel; Leruez-Ville Marianne; Maertens Anne; Mousnier Fabienne; Pasquier Christophe; Payan Christopher; Pellegrin Bertrand; Schvoerer Evelyne; Zavadzki Patricia; Chouteau Jacques; Duverlie Gilles; Izopet Jacques; Lunel-Fabiani Françoise; Pawlotsky Jean-Michel; Profizi Nerina; Rouzioux Christine; Stoll-Keller Françoise; Thibault Vincent; Wattré Pierre; Pozzetto Bruno
Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.
Journal of clinical microbiology 2003;41(2):789-93.
-
2003: Coste J; Levayer T; Izopet J; Laperche S; Parneix P; Rech H; Payen J L; Schved J F
Acute HCV infection detected in a blood donor by NAT.
Transfusion 2003;43(1):116-8.
-
2003: Kamar N; Izopet J; Rostaing L
[Hepatitis C infection among patients receiving hemodialysis]
Néphrologie 2003;24(3):133-41.
-
2003: Kamar N; Sandres-Saune K; Selves J; Durand D; Izopet J; Rostaing L
[Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?]
Néphrologie 2003;24(2):89-94.
-
2002: Descamps Diane; Flandre Philippe; Joly Véronique; Meiffrédy Vincent; Peytavin Gilles; Izopet Jacques; Tamalet Catherine; Zeng Ai-Feng; Harel Marine; Lastère Stéphane; Aboulker Jean-Pierre; Yéni Patrick; Brun-Vézinet Françoise;
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.
Journal of acquired immune deficiency syndromes (1999) 2002;31(5):464-71.
-
2002: Alric Laurent; Di-Martino Vincent; Selves Janik; Cacoub Patrice; Charlotte Frédéric; Reynaud Didier; Piette Jean-Charles; Péron Jean-Marie; Vinel Jean-Pierre; Durand Dominique; Izopet Jacques; Poynard Thierry; Duffaut Michel; Rostaing Lionel
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection.
Gastroenterology 2002;123(5):1494-9.
-
2002: Izopet Jacques; Souyris Corinne; Sandres-Sauné Karine; Puissant Bénédicte; Obadia Martine; Pasquier Christophe; Puel Jacqueline; Blancher Antoine; Massip Patrice
Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV-1 resistance genotype.
Journal of medical virology 2002;68(3):305-10.
-
2002: Izopet Jacques; Cazabat Michèle; Pasquier Christophe; Sandres-Sauné Karine; Bonnet Eric; Marchou Bruno; Massip Patrice; Puel Jacqueline
Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.
Virology 2002;302(2):393-404.
-
2002: Boulestin Anne; Sandres-Sauné Karine; Payen Jean-Louis; Alric Laurent; Dubois Martine; Pasquier Christophe; Vinel Jean-Pierre; Pascal Jean-Pierre; Puel Jacqueline; Izopet Jacques
Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.
Journal of medical virology 2002;68(2):221-8.
-
2002: Izopet Jacques; Souyris Corinne; Hance Allan; Sandres-Sauné Karine; Alvarez Muriel; Pasquier Christophe; Clavel François; Puel Jacqueline; Massip Patrice
Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.
The Journal of infectious diseases 2002;185(10):1506-10.
-
2002: Miédougé Marcel; Chatelut Martine; Mansuy Jean-Michel; Rostaing Lionel; Malecaze François; Sandres-Sauné Karine; Boudet Francis; Puel Jacqueline; Abbal Michel; Izopet Jacques
Screening of blood from potential organ and cornea donors for viruses.
Journal of medical virology 2002;66(4):571-5.
-
2001: Hrycewycz N; Sandres K; Barange K; Pascal J P; Izopet J; Payen J L
[Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C]
Gastroentérologie clinique et biologique 2001;25(11):1041-2.
-
2001: Mouroux M; Descamps D; Izopet J; Yvon A; Delaugerre C; Matheron S; Coutellier A; Valantin M A; Bonmarchand M; Agut H; Massip P; Costagliola D; Katlama C; Brun-Vezinet F; Calvez V
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Antiviral therapy 2001;6(3):179-83.
-
2001: Sandres K; Dubois M; Pasquier C; Puel J; Izopet J
Determination of HCV genotype using two antibody assays and genome typing.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(9):666-9.
-
2001: Ben Halima M; Pasquier C; Slim A; Ben Chaabane T; Arrouji Z; Puel J; Ben Redjeb S; Izopet J
First molecular characterization of HIV-1 Tunisian strains.
Journal of acquired immune deficiency syndromes (1999) 2001;28(1):94-6.
-
2001: Descamps D; Calvez V; Izopet J; Buffet-Janvresse C; Schmuck A; Colson P; Ruffault A; Maillard A; Masquelier B; Cottalorda J; Harzic M; Brun-Vézinet F; Costagliola D;
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
AIDS (London, England) 2001;15(14):1777-82.
-
2001: Alric L; Duffaut M; Selves J; Sandre K; Mularczyck M; Izopet J; Desmorat H; Bureau C; Chaouche N; Dalbergue B; Vinel J P
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial.
Journal of hepatology 2001;35(2):272-8.
-
2001: Masquelier B; Chaix M L; Burgard M; Lechenadec J; Doussin A; Simon F; Cottalorda J; Izopet J; Tamalet C; Douard D; Fleury H; Mayaux M J; Blanche S; Rouzioux C;
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):99-104.
-
2001: Masquelier B; Race E; Tamalet C; Descamps D; Izopet J; Buffet-Janvresse C; Ruffault A; Mohammed A S; Cottalorda J; Schmuck A; Calvez V; Dam E; Fleury H; Brun-Vézinet F;
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors.
Antimicrobial agents and chemotherapy 2001;45(6):1836-42.
-
2001: Pasquier C; Millot N; Njouom R; Sandres K; Cazabat M; Puel J; Izopet J
HIV-1 subtyping using phylogenetic analysis of pol gene sequences.
Journal of virological methods 2001;94(1-2):45-54.
-
2000: Burgard M; Izopet J; Dumon B; Tamalet C; Descamps D; Ruffault A; Vabret A; Bargues G; Mouroux M; Pellegrin I; Ivanoff S; Guisthau O; Calvez V; Seigneurin J M; Rouzioux C
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.
AIDS research and human retroviruses 2000;16(18):1939-47.
-
2000: Pellegrin I; Segondy M; Garrigue I; Izopet J; Montes B; Pellegrin J L; Reynes J; Massip P; Puel J; Fleury H
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;25(5):465-6.
-
2000: Izopet J; Massip P; Souyris C; Sandres K; Puissant B; Obadia M; Pasquier C; Bonnet E; Marchou B; Puel J
Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen.
AIDS (London, England) 2000;14(15):2247-55.
-
2000: Pasquier C; Daudin M; Righi L; Berges L; Thauvin L; Berrebi A; Massip P; Puel J; Bujan L; Izopet J
Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children.
AIDS (London, England) 2000;14(14):2093-9.
-
2000: Alric L; Fort M; Izopet J; Vinel J P; Bureau C; Sandre K; Charlet J P; Beraud M; Abbal M; Duffaut M
Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance.
Tissue antigens 2000;56(2):154-8.
-
2000: Mouroux M; Izopet J; Descamps D; Delaugerre C; Yvon-Groussin A; Angleraud F; Coutellier A; Bonmarchand M; Valantin M A; Matheron S; Agut H; Katlama C; Brun-Vezinet F; Calvez V
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T]
Pathologie-biologie 2000;48(5):508-12.
-
2000: Lesourd F; Izopet J; Mervan C; Payen J L; Sandres K; Monrozies X; Parinaud J
Transmissions of hepatitis C virus during the ancillary procedures for assisted conception.
Human reproduction (Oxford, England) 2000;15(5):1083-5.
-
2000: Salama G; Rostaing L; Sandres K; Izopet J
Hepatitis C virus infection in French hemodialysis units: a multicenter study.
Journal of medical virology 2000;61(1):44-51.
-
2000: Malavaud B; Dinh B; Bonnet E; Izopet J; Payen J L; Marchou B
Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
Antiviral therapy 2000;5(1):3-5.
-
2000: Rostaing L; Izopet J; Sandres K; Cisterne J M; Puel J; Durand D
Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil.
Transplantation 2000;69(5):991-4.
-
2000: Izopet J; Rostaing L; Sandres K; Cisterne J M; Pasquier C; Rumeau J L; Duffaut M; Durand D; Puel J
Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.
The Journal of infectious diseases 2000;181(3):852-8.
-
2000: Lefrère J J; Lerable J; Mariotti M; Bogard M; Thibault V; Frangeul L; Loiseau P; Bouchardeau F; Laperche S; Pawlotsky J M; Cantaloube J F; Biagini P; de Lamballerie X; Izopet J; Defer C; Lepot I; Poveda J D; Dussaix E; Gerolami V; Halfon P; Buffet-Janvresse C; Férec C; Mercier B; Marcellin P; Martinot-Peignoux M; Gassain M
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.
Journal of virological methods 2000;85(1-2):117-24.
-
2000: Sandres K; Dubois M; Pasquier C; Payen J L; Alric L; Duffaut M; Vinel J P; Pascal J P; Puel J; Izopet J
Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.
Journal of virology 2000;74(2):661-8.
-
1999: Malavaud B; Miédougé M; Payen J L; Izopet J; Rischmann P; Pascal J P; Sarramon J P; Serre G
Prostate-specific antigen in acute hepatitis and hepatocellular carcinoma.
The Prostate 1999;41(4):258-62.
-
1999: Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
Journal of medical virology 1999;59(4):507-11.
-
1999: Martinot-Peignoux M; Roudot-Thoraval F; Mendel I; Coste J; Izopet J; Duverlie G; Payan C; Pawlotsky J M; Defer C; Bogard M; Gerolami V; Halfon P; Buisson Y; Fouqueray B; Loiseau P; Lamoril J; Lefrere J J; Marcellin P
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.
Journal of viral hepatitis 1999;6(6):435-43.
-
1999: Reynes J; Denisi R; Massip P; Izopet J; Pellegrin I; Segondy M
Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.
Journal of acquired immune deficiency syndromes (1999) 1999;22(1):103-5.
-
1999: Pellegrin I; Izopet J; Reynes J; Denayrolles M; Montes B; Pellegrin J L; Massip P; Puel J; Fleury H; Segondy M
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.
AIDS (London, England) 1999;13(13):1705-9.
-
1999: Pasquier C; Sandres K; Salama G; Puel J; Izopet J
Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.
Journal of virological methods 1999;81(1-2):123-9.
-
1999: Alric L; Izopet J; Fort M; Vinel J P; Fontenelle P; Orfila C; Payen J L; Sandres K; Desmorat H; Charlet J P; Duffaut M; Abbal M
Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection.
Human immunology 1999;60(6):516-23.
-
1999: Izopet J; Pasquier C; Sandres K; Puel J; Rostaing L
Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit.
Journal of medical virology 1999;58(2):139-44.
-
1999: Alric L; Fort M; Izopet J; Vinel J P; Duffaut M; Abbal M
Association between genes of the major histocompatibility complex class II and the outcome of hepatitis C virus infection.
The Journal of infectious diseases 1999;179(5):1309-10.
-
1999: Chatelut E; Rostaing L; Grégoire N; Payen J L; Pujol A; Izopet J; Houin G; Canal P
A pharmacokinetic model for alpha interferon administered subcutaneously.
British journal of clinical pharmacology 1999;47(4):365-71.
-
1999: Rostaing L; Izopet J; Arnaud C; Cisterne J M; Alric L; Rumeau J L; Duffaut M; Durand D
Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients.
Transplantation 1999;67(4):556-60.
-
1999: Izopet J; Sailler L; Sandres K; Pasquier C; Bonnet E; Aquilina C; Puel J; Massip P; Marchou B
Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.
Journal of medical virology 1999;57(2):163-8.
-
1999: Masquelier B; Descamps D; Carrière I; Ferchal F; Collin G; Denayrolles M; Ruffault A; Chanzy B; Izopet J; Buffet-Janvresse C; Schmitt M P; Race E; Fleury H J; Aboulker J P; Yeni P; Brun-Vézinet F
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study.
Antiviral therapy 1999;4(2):69-77.
-
1999: Rostaing L; Izopet J; Arnaud C; Rumeau J L; Duffaut M; Cisterne J M; Durand D
[Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients]
Néphrologie 1999;20(3):165-70.
-
1998: Izopet J; Salama G; Pasquier C; Sandres K; Marchou B; Massip P; Puel J
Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(5):478-83.
-
1998: Rostaing L; Chatelut E; Payen J L; Izopet J; Thalamas C; Ton-That H; Pascal J P; Durand D; Canal P
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.
Journal of the American Society of Nephrology : JASN 1998;9(12):2344-8.
-
1998: Payen J L; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski J P; Seigneurin J M; Dussaix E; Voigt J J; Selves J; Barange K; Puel J; Pascal J P
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Hepatology (Baltimore, Md.) 1998;28(6):1680-6.
-
1998: Segondy M; Izopet J; Pellegrin I; Montes B; Dumon B; Pasquier C; Peeters M; Fleury H J; Puel J; Reynes J
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.
Journal of clinical microbiology 1998;36(11):3392-5.
-
1998: Pasquier C; Cayrou C; Blancher A; Tourne-Petheil C; Berrebi A; Tricoire J; Puel J; Izopet J
Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1.
Journal of virology 1998;72(11):8493-501.
-
1998: Rostaing L; Izopet J; Cisterne J M; Arnaud C; Duffaut M; Rumeau J L; Puel J; Durand D
Is long-term chronic immunosuppression therapy detrimental in hepatitis C virus-positive renal transplant patients?
Transplantation proceedings 1998;30(4):1312-3.
-
1998: Duverlie G; Khorsi H; Castelain S; Jaillon O; Izopet J; Lunel F; Eb F; Penin F; Wychowski C
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.
The Journal of general virology 1998;79 ( Pt 6)():1373-81.
-
1998: Payen J L; Izopet J; Barange K; Puel J; Selves J; Pascal J P
[Hepatitis C virus reinfection after an intravenous drug injection]
Gastroentérologie clinique et biologique 1998;22(4):469-70.
-
1998: Rostaing L; Izopet J; Cisterne J M; Arnaud C; Duffaut M; Rumeau J L; Puel J; Durand D
Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
Transplantation 1998;65(7):930-6.
-
1998: Izopet J; Payen J L; Alric L; Sandres K; Charlet J P; Vinel J P; Duffaut M; Pascal J P; Puel J
Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy.
Journal of medical virology 1998;54(2):86-91.
-
1998: Izopet J; Tamalet C; Pasquier C; Sandres K; Marchou B; Massip P; Puel J
Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.
Journal of medical virology 1998;54(1):54-9.
-
1998: Rostaing L; Modesto A; Cisterne J M; Izopet J; Oksman F; Duffaut M; Abbal M; Durand D
Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
American journal of nephrology 1998;18(1):50-6.
-
1997: Bogard M; Buffet-Janvresse C; Cantaloube J F; Biagini P; Duverlie G; Castelain S; Izopet J; Dubois M; Defer C; Lepot I; Coste J; Marcellin P; Martinot-Peignoux M; Halfon P; Gerolami V; Frangeul L; Pawlotsky J M; Roudot-Thoraval F; Dussaix E; Loiseau P; Ravera N; Lewin P; Lamoril J; Lerable J; Lebon P
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum.
Journal of clinical microbiology 1997;35(12):3298-300.
-
1997: Izopet J; Rostaing L; Moussion F; Alric L; Dubois M; That H T; Payen J L; Duffaut M; Durand D; Suc J M; Puel J
High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy.
The Journal of infectious diseases 1997;176(6):1614-7.
-
1997: Alric L; Fort M; Izopet J; Vinel J P; Charlet J P; Selves J; Puel J; Pascal J P; Duffaut M; Abbal M
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.
Gastroenterology 1997;113(5):1675-81.
-
1997: Khorsi H; Castelain S; Wyseur A; Izopet J; Canva V; Rombout A; Capron D; Capron J P; Lunel F; Stuyver L; Duverlie G
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients.
Journal of hepatology 1997;27(1):72-7.
-
1997: Lafeuillade A; Tamalet C; Poggi C; Pellegrino P; Tourres C; Izopet J
Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes.
AIDS (London, England) 1997;11(1):67-72.
-
1997: Izopet J; Rostaing L; Ton-That H; Dubois M; Cazabat M; Charlet J P; Sayada C; Duffaut M; Durand D; Puel J
Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy.
American journal of nephrology 1997;17(5):417-20.
-
1997: Rostaing L; Izopet J; Cisterne J M; Icart J; Chabannier M H; Panicali H; Durand D
Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
American journal of nephrology 1997;17(1):46-52.
-
1996: Rostaing L; Izopet J; Cisterne J M; Baron E; Rumeau J L; Chabannier M H; Duffaut M; Durand D
Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
Scandinavian journal of urology and nephrology 1996;30(6):485-7.
-
1996: Lina B; Pozzetto B; Andreoletti L; Beguier E; Bourlet T; Dussaix E; Grangeot-Keros L; Gratacap-Cavallier B; Henquell C; Legrand-Quillien M C; Novillo A; Palmer P; Petitjean J; Sandres K; Dubreuil P; Fleury H; Freymuth F; Leparc-Goffart I; Hober D; Izopet J; Kopecka H; Lazizi Y; Lafeuille H; Lebon P; Roseto A; Marchadier E; Masquelier B; Picard B; Puel J; Seigneurin J M; Wattre P; Aymard M
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens.
Journal of clinical microbiology 1996;34(12):3002-6.
-
1996: Rostaing L; Rumeau J L; Cisterne J M; Izopet J; Chabannier M H; Durand D
Liver histology in renal transplant patients after more than 10 years of hepatitis C virus infection.
Transplantation proceedings 1996;28(5):2836-7.
-
1996: Izopet J; Poggi C; Dussaix E; Mansuy J M; Cubaynes L; Profizi N; Lafeuillade A; Marchou B; Massip P; Sayada C; Puel J
Assessment of a standardized reverse-transcriptase PCR assay for quantifying HIV-1 RNA in plasma and serum.
Journal of virological methods 1996;60(2):119-29.
-
1996: Rostaing L; Oksman F; Izopet J; Baron E; Cisterne J M; Hoff M; Abbal M; Durand D
Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
American journal of nephrology 1996;16(6):478-83.
-
1996: Cisterne J M; Rostaing L; Izopet J; Chabannier M H; Baron E; Duffaut M; Durand D; Suc J M
Epidemiology of HCV infection: disease and renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 4():46-7.
-
1996: Payen J L; Izopet J
[Does a healthy carrier of hepatitis C exist?]
Gastroentérologie clinique et biologique 1996;20(6-7):531-4.
-
1995: Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Transplantation 1995;59(10):1426-31.
-
1995: Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.
Transplantation proceedings 1995;27(1):948-50.
-
1995: Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D; Suc J M
Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10 Suppl 6():93-6.
Sign-in to see more
